Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 18/20 | 0.84 |
| ▸ | IGF1R | P08069 | 17/20 | 0.84 |
| ▸ | KDR | P35968 | 16/20 | 0.84 |
| ▸ | MST1R | Q04912 | 2/20 | 0.84 |
| ▸ | AURKA | O14965 | 1/20 | 0.84 |
| ▸ | JAK2 | O60674 | 1/20 | 0.84 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.84 |
| ▸ | ABL1 | P00519 | 1/20 | 0.84 |
| ▸ | INSR | P06213 | 1/20 | 0.84 |
| ▸ | LCK | P06239 | 1/20 | 0.84 |
| ▸ | FES | P07332 | 1/20 | 0.84 |
| ▸ | CSF1R | P07333 | 1/20 | 0.84 |
| ▸ | LYN | P07948 | 1/20 | 0.84 |
| ▸ | RET | P07949 | 1/20 | 0.84 |
| ▸ | FGR | P09769 | 1/20 | 0.84 |
| ▸ | KIT | P10721 | 1/20 | 0.84 |
| ▸ | PIM1 | P11309 | 1/20 | 0.84 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.84 |
| ▸ | SRC | P12931 | 1/20 | 0.84 |
| ▸ | PRKACA | P17612 | 1/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20386700 | 0.93 | MET (0.79) | METIGF1RKDRMST1RAURKA | |
| SCHEMBL29388975 | 0.92 | MET (1.00) | METIGF1RKDRMST1RAURKA | |
| SCHEMBL29395221 | 0.92 | MET (1.00) | METIGF1RKDRMST1RAURKA | |
| SCHEMBL197714 | 0.92 | MET (1.00) | METIGF1RKDRMST1RAURKA | |
| SCHEMBL200756 | 0.92 | MET (0.87) | METIGF1RKDRMST1RAURKA | |
| SCHEMBL19705828 | 0.92 | MET (0.77) | METIGF1RKDRMST1RAURKA | |
| SCHEMBL20386699 | 0.90 | MET (0.86) | METIGF1RKDRMST1RAURKA | |
| SCHEMBL199743 | 0.89 | IGF1R (0.87) | METIGF1RKDRMST1RAURKA | |
| SCHEMBL901350 | 0.84 | MET (0.86) | METIGF1RKDRMST1RAURKA | |
| SCHEMBL20386698 | 0.82 | MET (0.85) | METIGF1RKDRMST1RAURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10716801-B2 | Silanol based therapeutic payloads | BLINKBIO, INC. (US) | 2020-07-21 | — | — | US | disclosed |
| US-20190183913-A1 | Silanol Based Therapeutic Payloads | BLINKBIO INC (US) | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190183913-A1 | Silanol Based Therapeutic Payloads | CD47, CD4, BST2 | MET 280/4885IGF1R 3222/4885KDR 1130/4885 |
| US-10716801-B2 | Silanol based therapeutic payloads | CD47, CD4, BST2 | MET 280/4885IGF1R 3222/4885KDR 1130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.